Table 1 Patient characteristics and baseline echocardiographic data

Age

73.0 ± 7.0

80.9 ± 6.4

<0.001

Male gender, n (%)

34 (74)

28 (54)

0.041

STS Mortality (%)

2.06 ± 0.6

6.03 ± 3.4

<0.001

BMI (kgm⁻²)

27.5 ± 4.4

27.0 ± 3.8

0.709

Previous MI, n (%)

6 (13)

9 (17)

0.560

Previous PCI, n (%)

1 (2)

14 (27)

0.001

Previous CABG, n (%)

1 (2)

17 (33)

<0.001

Stroke/TIA, n (%)

6 (13)

8 (15)

0.742

Peripheral vascular disease, n (%)

1 (2)

10 (19)

0.008

Hypertension

32 (70)

25 (48)

0.032

Diabetes Mellitus, n (%)

7 (15)

10 (19)

0.602

Hyperlipidaemia, n (%)

23 (50)

31 (60)

0.342

COPD, n (%)

4 (9)

12 (23)

0.056

Atrial Fibrillation, n (%)

3 (7)

15 (29)

0.005

eGFR (ml/min/1.73 m²)

73.3 ± 13.8

59.8 ± 18.9

<0.001

AVA (cm²)

0.83 ± 0..46

0.59 ± 0.17

<0.001

Mean aortic valve PG (mmHg)

46.9 ± 13.4

53.2 ± 19.2

0.102

Pulmonary Hypertension^a, n (%)

7 (15)

15 (29)

0.110

ValvuloArterial Impedance (Z_va)

3.73 ± 0.99

3.71 ± 1.09

0.734